Watch the webinar recording to explore the clinical aspects of heart failure and the clinical utility of Natriuretic Peptide assays within Asia Pacific
- Pathophysiology of Heart Failure and its position in the Continuum of Cardiovascular Disease
- Diagnosis and Classification of Heart Failure: Introduction to the Universal Definition of Heart Failure Consensus Statement published in April 2021
- Brief overview of the clinical management of Heart Failure
- The importance of Natriuretic Peptides (BNP and NT-proBNP) in the diagnosis, prognosis and management of Heart Failure
- Clinical utility of Natriuretic Peptide assays in Asia Pacific - best practice sharing from AP region
This webinar is organized in collaboration with the Malaysian Association of Clinical Biochemists (MACB) in an effort to advance online education for medical professionals.
Webinar Details
Date: 6 May 2021 | Thursday
Time: 2.30 pm - 3.30 pm Malaysia time
Location: Microsoft TeamsFor a smoother webinar experience, please click on the link below to download the Microsoft Teams application to your computer or device that you will be using for this session.Download Microsoft Teams
Time: 2.30 pm - 3.30 pm Malaysia time
Location: Microsoft TeamsFor a smoother webinar experience, please click on the link below to download the Microsoft Teams application to your computer or device that you will be using for this session.Download Microsoft Teams
Dr Pearline Teo
Dr Pearline Teo received her training in Biology and Immunology from Johns Hopkins University and Stanford University. Since then, she has had more than 10 years of basic, applied and clinical R&D experience in academia and industry, working with various types of products in the medical device and IVD space. Dr Teo has been awarded 2 US patents, and her peer reviewed publications have more than 3500 citations. At Siemens Healthineers, Dr Teo is responsible for clinical education, clinical trials and scientific communications.
Thank you for all the registrations!
Registration is now closed. Please email us at communications-shsb.my@siemens.com if you have any questions!
Nothing on this website or any publication materials of the event (e.g. invitation, brochures, flyer, etc.) creates an obligation on Siemens Healthcare Sdn Bhd or any of its affiliates, including any entities within the Siemens group or any of its or their officers, directors, employees and partners (collectively, the “Siemens Group”) to accept registration(s) for the webinar. Siemens Group reserves the right to accept or reject registration(s) received at its sole discretion and without cause, and any such decisions made shall be final.